Related Experiment Video

Updated: May 18, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Targeting the estrogen receptor using steroid-therapeutic drug conjugates (hybrids)

Kinh-Luan Dao1, Robert N Hanson

  • 1Department of Chemistry and Chemical Biology Department, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA.

Bioconjugate Chemistry
|October 6, 2012
PubMed

Insights

Targeting estrogen receptors (ER) in breast cancer offers a path for drug delivery. Researchers developed novel steroid-drug conjugates, achieving enhanced antiproliferative activity and ER-selectivity for potential clinical use.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Estrogen receptor (ER) is a key target in hormonally responsive breast cancer.
  • ER overexpression on breast cancer cells enables targeted drug delivery.
  • Steroidal estrogens' high affinity and selectivity are exploited for targeted therapies.

Purpose of the Study:

  • To review strategies for developing steroid-drug conjugates for enhanced antiproliferative activity and ER-selectivity.
  • To analyze the evolution of steroid scaffolds and drug conjugation sites.
  • To explain the failure of previous ER-targeted drug delivery efforts.

Main Methods:

  • Review of research efforts over 30 years in developing steroid-drug conjugates.
  • Analysis of choices in steroid scaffolds and drug conjugation sites.
  • Examination of estrogen and antiestrogen mechanisms of action.

Main Results:

  • Most previous efforts to develop ER-targeted conjugates failed to meet objectives.
  • Significant evolution in conjugate design based on ER function understanding.
  • A novel conjugate demonstrated clear achievement of antiproliferative activity and ER-selectivity.

Conclusions:

  • Steroid-drug conjugates offer a promising approach for targeted breast cancer therapy.
  • Understanding ER mechanisms is crucial for successful conjugate design.
  • A new conjugate provides a viable strategy for future clinical agents.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...